ASCEND: Safety and Tolerability of ION337 for the Treatment of Dravet Syndrome
Clinical trial NCT07531745 · RECRUITING
Trial details
- NCT number
- NCT07531745
- Sponsor
- Ionis Pharmaceuticals, Inc.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-21
- Primary completion
- 2030-12-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.